A display contains frozen items, and the shelves are stocked with jars and cans. But there’s just one reason to visit this Boerum Hill business: meat.
NYS Entity Status
NYS Filing Date
FEBRUARY 04, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - FIRST BUSINESS CONSULTANTS INC.
Around the Web
- Neighborhood Joint: Staubitz Market in Brooklyn: 100 Years of Sawdust, Steaks and Chops
By ANDREW COTTO - Wednesday Jun 14, 2017
- 19th-Century Diary Suggests Slaves Are Buried in Brooklyn Lot
By MICHAEL WILSON - Friday Aug 4, 2017
A Gowanus farmer’s writings from 1828 to 1830 describe burying them on property that includes the proposed site of a prekindergarten.
- View From the River Café: 40 Years of Feasts and Firsts
By BRYAN MILLER - Monday Jul 31, 2017
This special-occasion restaurant on the East River in Brooklyn was in many ways a pioneer, yet its understated charm and elegant owner still thrive.
- SUMMER FIRSTS | Brooklyn: Finding Alchemy and Art on a Coney Island Scary Ride
By FRANCINE PROSE - Wednesday Aug 2, 2017
For Francine Prose, an amusement-park trip as a young girl led to a ride on the Spook-a-Rama and later to a prized Diane Arbus photo of the same ride.
- MBAs are snubbing Wall Street to work at consulting firms
By Kevin Dugan - Wednesday Aug 9, 2017
It’s official: McKinsey & Co. is sexier than Goldman Sachs. The most sought-after jobs for MBAs are no longer on Wall Street, as more business students than ever before are instead looking to go into consulting, according to a survey released Wednesday. For the first time in eight years, consulting firms like McKinsey, Bain &...
- Cancer drug research moving fast in immunotherapy field
By Michelle Fay Cortez - Tuesday Sep 5, 2017
The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.